612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster I

Latency between detectable low-level measurable residual disease (MRD) by next-generation sequencing and overt relapse following flow cytometry MRD-negative remission in patients with acute lymphoblastic leukemia

Survival outcomes in therapy related acute lymphoblastic leukemia A population based analysis from SEER 2000–2022

Safety of lumbar puncture in adult patients with acute lymphoblastic leukemia and thrombocytopenia A retrospective study

Disease characteristics and outcomes of acute lymphoblastic leukemia ALL in adults with central nervous system CNS involvement

Mutations in IDH1 and IDH2 portend a poor prognosis in adult patients with acute lymphoblastic leukemia

Use and outcomes following blinatumomab rechallenge in adolescents and young adults AYA and adults with B cell acute lymphoblastic leukemia B ALL

Fixed dose inotuzumab ozogamicin combined with vincristine and prednisone regimen as induction therapy for newly diagnosed B cell acute lymphocytic leukemia

Temporal trends in treatment outcomes of acute lymphoblastic leukemia in Japan Progress and unmet needs

Venetoclax in combination with hypomethylating agents are effective salvage therapy in relapse refractory ETP ALL and near ETP ALL

Patient reported quality of life in Chinese children with B cell acute lymphoblastic leukemia receiving first line treatment with blinatumomab

Impact of therapy delays on outcomes in adults with BCR ABL1 negative b lineage acute lymphoblastic leukemia ALL in the ECOG ACRIN E1910 trial randomized to conventional chemotherapy blinatumomab

Targeting the sanctuary sites Allogeneic CD19 CAR T therapy for extramedullary relapsed B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Beyond MRD The importance of weight recovery in adults with ALL

Impact of uncontrolled hyperglycemia during induction chemotherapy on response and survival outcomes in patients with adult B cell acute lymphoblastic leukemia B ALL on HCVAD based regimens

Predicting mortality in ICU patients with acute leukemias A new risk score

Obesity is associated with poor prognosis in ph like acute lymphoblastic leukemia

Real world survival outcomes of Japanese adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia treated with ponatinib

Effectiveness and prognostic impact of BMI MRD and CNS involvement in AYA patients with Philadelphia negative ALL treated using the AYA 15 protocol Real world from a tertiary center in the middle east